Hypertension in Breast Cancer Patients Receiving Bevacizumab

NCT00674011 · clinicaltrials.gov ↗

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Breast Cancer

Interventions

DRUG: Bevacizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]